Efficacy of autologous platelet-rich fibrin compared to normal saline in the management of chronic venous leg ulcers: A randomized controlled trial
Phlebology: The Journal of Venous Disease · 12.03.2026
DOI: 10.1177/02683555261433271 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Phlebology: The Journal of Venous Disease, online erschienen am 12.03.2026. Verfasst von Pallaprolu Jyothirmai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, King George's Medical University, Lucknow, Uttar Pradesh (U.P.), India. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Objective
To compare the efficacy of Autologous Platelet-Rich Fibrin (PRF) versus Normal Saline (NS) dressings in healing Chronic Venous Leg Ulcers (CVLUs), focusing on ulcer area reduction and quality of life.
Methods
A randomized controlled trial was conducted at a tertiary care center involving 74 patients with chronic venous leg ulcers (CVLUs). Patients were randomized into two groups: Group A (n = 36) received autologous platelet-rich fibrin (PRF) dressings with four-layer compression therapy, while Group B (n = 38) received Normal Saline (NS) dressings with four-layer compression therapy. Ulcer area and Quality of Life were assessed at baseline and at predefined intervals up to 4 weeks, with continued follow-up for 6 months. The quality of life was assessed using the Charing Cross Venous Ulcer Questionnaire (CCVUQ) and the EuroQol-5 Dimension-5 Level (EQ-5D-5L) scores.
Results
Both groups showed a reduction in ulcer area over time. In the PRF group, mean ulcer area decreased significantly from baseline to 4 weeks (17.46 ± 11.52 cm 2 to 9.92 ± 8.73 cm 2 ; p = 0.007), whereas the reduction in the saline group was not statistically significant (14.07 ± 14.43 cm 2 to 11.45 ± 12.02 cm 2 ; p = 0.913). Between-group comparison at 4 weeks was not significant; however, from 4 weeks onward, the PRF group consistently demonstrated smaller mean ulcer areas, with the greatest difference observed at 6 months. CCVUQ and EQ-5D-5L scores improved over time in both groups, with a transient between-group difference favoring PRF at 4 weeks for CCVUQ but no sustained head-to-head superiority in quality-of-life outcomes.
Conclusion
Autologous PRF, when used as an adjunct to standard compression therapy, is associated with earlier and sustained reduction in ulcer area and improvement in ulcer-related Quality-of-Life in patients with chronic venous leg ulcers. No treatment related adverse events were observed during the study period.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, King George's Medical University, Lucknow, Uttar Pradesh (U.P.), India.
- Department of Transfusion Medicine, King George's Medical University, Lucknow, Uttar Pradesh (U.P.), India.
- Department of Thoracic Surgery, King George's Medical University, Lucknow, Uttar Pradesh (U.P.), India.
ORCID-Profile: Pallaprolu Jyothirmai
Zitieren
APA
Jyothirmai, P., Kushwaha, J. K., Singh, S., Chandra, T., Yadav, S. K., Singh, K. K., & Sonkar, A. A. (2026). Efficacy of autologous platelet-rich fibrin compared to normal saline in the management of chronic venous leg ulcers: A randomized controlled trial. Phlebology: The Journal of Venous Disease. https://doi.org/10.1177/02683555261433271
Vancouver
Jyothirmai P, Kushwaha JK, Singh S, Chandra T, Yadav SK, Singh KK, et al. Efficacy of autologous platelet-rich fibrin compared to normal saline in the management of chronic venous leg ulcers: A randomized controlled trial. Phlebology: The Journal of Venous Disease. 2026. doi:10.1177/02683555261433271
BibTeX
@article{Jyothirmai2026,
author = {Jyothirmai, Pallaprolu and Kushwaha, Jitendra Kumar and Singh, Saumya and Chandra, Tulika and Yadav, Shailendra Kumar and Singh, Krishna Kant and Sonkar, Abhinav Arun},
title = {Efficacy of autologous platelet-rich fibrin compared to normal saline in the management of chronic venous leg ulcers: A randomized controlled trial},
journal = {Phlebology: The Journal of Venous Disease},
year = {2026},
doi = {10.1177/02683555261433271}
}
EUVIMED